Examkin

Soru

Zorluk: OrtaMonitoring and Treatment Evaluation

A 65-year-old woman is brought to the emergency department after a witnessed generalized tonic-clonic seizure. Her family reports she has been feeling progressively lethargic and confused over the past 3 days while recovering from a severe gastrointestinal illness. Initial laboratory evaluation reveals a serum sodium level of 112 mEq/L. She is diagnosed with severe symptomatic hyponatremia. Arrange the following management and monitoring steps in the correct chronological sequence, from initial emergency intervention to ongoing maintenance.

  1. 1Administer an initial 100-150 mL bolus of 3% hypertonic saline intravenously.
  2. 2Recheck the serum sodium concentration and reassess neurological status 20 minutes after the infusion.
  3. 3Discontinue hypertonic saline once acute neurological symptoms resolve and sodium increases by 4-6 mEq/L.
  4. 4Transition to cause-specific therapy such as fluid restriction or isotonic fluids.
  5. 5Continue monitoring serum sodium every 6 to 8 hours to ensure 24-hour correction does not exceed 8 mEq/L.

Cevap

The correct sequence involves immediate administration of 3% hypertonic saline to treat the seizure, followed by a rapid recheck of the sodium level at 20 minutes. Once symptoms resolve and sodium has increased by a safe margin of 4-6 mEq/L, the hypertonic saline is stopped. Management then transitions to cause-specific therapy, followed by ongoing monitoring every 6 to 8 hours to prevent overcorrection and osmotic demyelination syndrome.
Severe symptomatic hyponatremia requires a carefully phased approach to management and monitoring. The initial objective is to rapidly reverse life-threatening cerebral edema using a bolus of 3% hypertonic saline, followed by an immediate 20-minute sodium recheck to confirm the expected 1-2 mEq/L rise. Once the patient's acute symptoms (such as seizures) resolve and the sodium level has risen by a safe threshold of 4-6 mEq/L, the emergency phase is effectively complete. At this point, hypertonic saline must be discontinued to avoid rapid overcorrection. The management focus then shifts to cause-specific therapy directed at the underlying pathophysiology. Finally, less frequent but vigilant monitoring (every 6 to 8 hours) is instituted to ensure the 24-hour correction limit of 8 mEq/L is strictly maintained, which is critical for preventing osmotic demyelination syndrome.

Adım Adım Çözüm

1
Administer an initial 100-150 mL bolus of 3% hypertonic saline intravenously.
The hypertonic load begins to draw fluid out of the brain tissue.
To rapidly reverse life-threatening cerebral edema and stop the seizure activity.
2
Recheck the serum sodium concentration and reassess neurological status 20 minutes after the infusion.
The physician confirms whether the sodium has appropriately risen by 1-2 mEq/L.
To evaluate the immediate clinical response and determine if an additional hypertonic bolus is required.
3
Discontinue hypertonic saline once acute neurological symptoms resolve and sodium increases by 4-6 mEq/L.
The acute phase of therapy is safely terminated.
To prevent accidental overcorrection once the brain is out of immediate danger.
4
Transition to cause-specific therapy such as fluid restriction or isotonic fluids.
The patient begins maintenance therapy directed at the primary volume status and etiology.
To address the root cause of the hyponatremia now that the neurological emergency is stabilized.
5
Continue monitoring serum sodium every 6 to 8 hours to ensure 24-hour correction does not exceed 8 mEq/L.
The rate of sodium correction is strictly controlled over the subsequent days.
To prevent osmotic demyelination syndrome caused by excessively rapid sodium correction.

Anahtar Kavram

Monitoring and adjusting the rate of sodium correction in severe symptomatic hyponatremia
Bu soruyu puanla

Konular

Monitoring and Treatment Evaluation

Bu konudan daha fazla soru